0001104659-19-045979.txt : 20190814
0001104659-19-045979.hdr.sgml : 20190814
20190814192706
ACCESSION NUMBER: 0001104659-19-045979
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190813
FILED AS OF DATE: 20190814
DATE AS OF CHANGE: 20190814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUFFOLO ROBERT R
CENTRAL INDEX KEY: 0001187308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38630
FILM NUMBER: 191028043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001614067
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320074500
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5941 OPTICAL COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95138
BUSINESS PHONE: (408) 385-1742
MAIL ADDRESS:
STREET 1: 5941 OPTICAL COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95138
4
1
a4.xml
4
X0306
4
2019-08-13
0
0001614067
Aridis Pharmaceuticals, Inc.
ARDS
0001187308
RUFFOLO ROBERT R
C/O ARIDIS PHARMACUETICALS, INC.
5491 OPTICAL CT.
SAN JOSE
CA
95138
1
0
0
0
Stock Options
8.39
2019-08-13
4
A
0
35000
0
A
2029-08-13
Common Stock
35000
42791
D
The shares underlying this stock option vest in equal monthly installments over the 36 months following the date of grant.
/s/ Robert Ruffolo
2019-08-14